Hypertrophic cardiomyopathy 1
MONDO:0008647Any hypertrophic cardiomyopathy in which the cause of the disease is a mutation in the MYH7 gene.
Also known as: CMH1, MYH7 hypertrophic cardiomyopathy, cardiomyopathy, familial hypertrophic, Autosomal dominant, Digenic dominant, cardiomyopathy, familial hypertrophic, type 1, cardiomyopathy, hypertrophic, 1, Autosomal dominant, Digenic dominant, cardiomyopathy, hypertrophic, 1, digenic, Autosomal dominant, Digenic dominant, hypertrophic cardiomyopathy 1, hypertrophic cardiomyopathy caused by mutation in MYH7
8 clinical trials for this condition and its sub-types, 0 tagged with Hypertrophic cardiomyopathy 1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could a short course of steroids calm a dangerous heart rhythm?
Disease control By invitation onlyThis trial tests whether an 8-week course of the immunosuppressive drug prednisone can reduce episodes of ventricular tachycardia (a potentially fatal fast heart rhythm) and improve heart function in people with non-ischemic cardiomyopathy and confirmed heart inflammation. Partic…
Phase 4 • Sponsor: Roderick Tung • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Super MRI could spot hidden heart damage
Diagnosis OngoingThis study tests whether a new, more powerful 7 Tesla MRI can better detect scarring and swelling in the heart muscle of people with cardiomyopathy. Researchers will scan 13 adults aged 20-70 to see if the higher-resolution images improve diagnosis. The goal is to see if this adv…
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Can a gene registry unlock the secrets of childhood heart failure?
Knowledge-focused OngoingThis study gathers health information from children under 18 who have cardiomyopathy linked to mutations in the MYBPC3 gene. Researchers aim to map the disease's natural course, identify risk factors, and measure how it affects quality of life. By reviewing past and future medica…
Sponsor: Tenaya Therapeutics • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC